Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -140 | -3,990 | -1,890 | -1,150 |
| Depreciation Amortization | N/A | 190 | 1,660 | 1,410 | 10 |
| Other Working Capital | N/A | 2,100 | 3,030 | 1,660 | 940 |
| Other Operating Activity | 0 | -2,240 | 0 | 130 | 200 |
| Operating Cash Flow | $N/A | $-90 | $700 | $1,310 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -170 | -220 | -250 | 0 |
| Other Investing Activity | 0 | 0 | 0 | -110 | -100 |
| Investing Cash Flow | $N/A | $-170 | $-220 | $-360 | $-100 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 50 | 10 |
| Financing Cash Flow | $N/A | $0 | $0 | $50 | $10 |
| Exchange Rate Effect | N/A | 70 | -10 | 0 | 0 |
| Beginning Cash Position | N/A | 1,480 | 1,020 | 20 | 120 |
| End Cash Position | N/A | 1,290 | 1,480 | 1,020 | 20 |
| Net Cash Flow | $N/A | $190 | $460 | $1,000 | $-90 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -90 | 700 | 1,310 | 0 |
| Free Cash Flow | 0 | -90 | 700 | 1,310 | 0 |